source
- Michael J. Fox Foundation backs Ariadne Bio's non-hallucinogenic psychedelic for Parkinson'sAriadne Bio, a new biotech focused on Parkinson's disease, has received backing from the Michael J. Fox Foundation. The partnership centers on a non‑hallucinogenic psychedelic candidate that the fo…
- Biotech sector expected to weather Fed rate hike despite higher capital costsThe Federal Reserve raised the federal funds rate by a quarter of a percentage point, a move that traditionally weighs on capital‑intensive industries like biotech. Analysts at BMO Capital Markets…